Healthequity Inc(HQY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 AM ET (Korea 9/11 17:00)
Full metrics table
| Index | RUT | P/E | 34.15 | EPS (ttm) | 2.77 | Insider Own | 2.62% | Shs Outstand | 82.9M | Perf Week | -4.05% |
| Market Cap | 7.82B | Forward P/E | 17.19 | EPS next Y | 16.43% | Insider Trans | -1.16% | Shs Float | 80.5M | Perf Month | -10.44% |
| Enterprise Value | 8.54B | PEG | 1.2 | EPS next Q | 1.15 | Inst Own | 109.55% | Short Float | 5.11% | Perf Quarter | 5.38% |
| Income | 0.24B | P/S | 5.74 | EPS this Y | 18.1% | Inst Trans | 3.01% | Short Ratio | 4.76 | Perf Half Y | 20.34% |
| Sales | 1.36B | P/B | 3.94 | EPS next 5Y | 14.33% | ROA | 7.07% | Short Interest | 4.12M | Perf YTD | 3.21% |
| Book/sh | 24 | P/C | 30.55 | EPS past 3/5Y | - 83.98% | ROE | 11.43% | 52W High | -12.14% ($107.62) | Perf Year | 3.32% |
| Cash/sh | 3.09 | P/FCF | 16.03 | Sales past 3/5Y | 15.08% 12.36% | ROIC | 8.01% | 52W Low | 29.95% ($72.76) | Perf 3Y | 38.98% |
| Dividend Est. | - | EV/EBITDA | 16.62 | EPS Y/Y TTM | 65.97% | Gross Margin | 63.41% | Volatility(W/M) | 2.56% 3% | Perf 5Y | 48.22% |
| Dividend TTM | - | EV/Sales | 6.27 | Sales Y/Y TTM | 7.33% | Oper. Margin | 26.12% | ATR (14) | 3.29 | Perf 10Y | 183.85% |
| Dividend Ex-Date | - | Quick Ratio | 2.99 | EPS Q/Q | 14.56% | Profit Margin | 17.36% | RSI (14) | 40.19 | Recom | 1.18 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.99 | Sales Q/Q | 7.65% | SMA20 | -5.52% ($100.07) | Beta | 0.24 | Target Price | $119 |
| Payout | - | Debt/Eq | 0.49 | Earnings | 2026/8/27 | SMA50 | -4.98% ($99.51) | Rel Volume | 0.79 | Prev Close | $92.66 |
| Employees | 2814 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 3.92% 0.42% | SMA200 | 5.94% ($89.25) | Avg Volume(3M) | 0.86M | Price | $94.55 |
| IPO | 2014/7/31 | Option/Short | Yes/Yes | Trades | 11271 | Volume | 684,003 | Change | 2.04% |
Company
HQY is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US healthcare fintech company that manages health savings accounts (HSAs) and consumer-directed healthcare benefits. It operates and custodies tax-advantaged HSAs and offers related benefits services, making it a healthcare information services stock whose performance is tied to account growth, assets under deposit, and the interest rate environment.
Over the past 1 year, roughly in the middle
12% below its 1-year high.
HQY makes money exceptionally well
26.12% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +18.1% this year.
Tap to view numbers
The price looks about right
Trading at 34.1 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +39.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 109.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
KNOW 0.06%
BOUT 0.06%
TMFM 0.05%
TMFS 0.04%
SMCO 0.02%It ranks #4 in the industry
Based on market cap of $8B.
HQY $8B PER 34.1
VEEV $42B PER 42.9
BTSG $11B PER 43.2
TEM $11B PER -
FAQ
What kind of company is HQY?
HQY belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of HQY?
The market cap of HQY is approximately $7.8B, ranking 1,086 within its sector.
What is the P/E ratio of HQY?
HQY has a P/E ratio of approximately 34.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for HQY?
HQY has recorded a 52-week high of $107.62 and a low of $72.76.
